Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sufentanil Pharmacokinetics After Intra-amniotic Injection
NCT02962830Phase 2Completed
- Sponsor
- CHU de Lille
- Start
- Apr 2017
- Primary completion
- May 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of sufentanil, sponsored by CHU de Lille. Started Apr 2017; status: completed.
02
Drugs
sufentanil
Beyond the preview
Go deeper on NCT02962830.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02962830.